CHRONICALLY IMPLANTED ABDOMINAL PRESSURE SENSOR FOR CONTINUOUS AMBULATORY ASSESSMENT OF RENAL FUNCTIONS

• US 20130144174A1
• Filed: 11/12/2012
• Published: 06/06/2013
• Est. Priority Date: 09/12/2008
• Status: Abandoned Application

• Current Assignee: Binh C. Tran, Bin Mi, John D. Hatlestad, Ronald W. Heil Jr
• Original Assignee: Ronald W. Heil Jr
• Inventors: Hatlestad, John D., Mi, Bin, Heil, Ronald W. Jr., Tran, Binh C
• Application Number:
  US13/674,639
• Publication Number:
  US 20130144174A1
• Time in Patent Office: Days
• US Class Current: 600/483
• CPC Class Codes: A61B 5/0028 Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/0205 Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
• CPC Class Codes: A61B 5/03 Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs A61B5/205 takes precedence
• CPC Class Codes: A61B 5/036 by means introduced into body tracts A61B5/032 and A61B5/035 take precedence
• CPC Class Codes: A61B 5/201 Assessing renal or kidney functions
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/6846 specially adapted to be brought in contact with an internal body part, i.e. invasive

Abstract

An implantable system for ambulatory monitoring of a high-risk heart failure patient includes a first pressure sensor implantable within an abdomen of the patient for sensing and generating an output representative of a baseline intra-abdominal pressure value of the patient and for chronically sensing and generating an output representative of an intra-abdominal pressure value of the patient at periodic intervals. At least one second implantable sensor is provided for sensing and generating an output representative of a second physiological parameter of the patient. Additionally, the system includes a processor for correlating the output of the first pressure sensor and the second physiologic sensor, and for comparing differences between the baseline intra-abdominal pressure value and subsequent intra-abdominal pressure values. The processor can reside in another implantable device or in an external device/system.

Claims

1-19. -19. (canceled)

20. A method of monitoring heart functions of a patient, the method comprising:

measuring a first set of intra-abdominal pressure values of the patient using at least one pressure sensor chronically implanted at least partially within an abdomen of the patient;

chronically measuring a plurality of second sets of intra-abdominal pressure values of the patient at periodic intervals using the at least one pressure sensor;

remotely transmitting the first and second sets of intra-abdominal pressure values to one or both of an external device and an implant within the patient;

comparing the first set of intra-abdominal pressure values to at least one of the plurality of the second sets of intra-abdominal pressure values; and

determining if there is a difference between the first set of intra-abdominal pressure values and any one or a plurality of the second sets of intra-abdominal pressure values that exceeds a predetermined threshold value that can be attributed to a renal condition linked to heart function.

21. The method of claim 20, further comprising adjusting a therapy based on the difference between the first set of intra-abdominal pressure values and any one or a plurality of the second sets of intra-abdominal pressure values.

22. The method of claim 21, wherein the therapy is a renal therapy.

23. The method of claim 20, further comprising sending a signal to an external device if the difference between the first set of intra-abdominal pressure values and any one or a plurality of the second sets of intra-abdominal pressure values is greater than the predetermined threshold value.

24. The method of claim 23, wherein the predetermined threshold value is about 8 mmHg.

25. The method of claim 20, further comprising associating the second set of intra-abdominal pressure values with an output from at least one implantable physiologic sensor.

26. The method of claim 25, wherein the at least one implantable physiologic sensor may comprise a posture sensor or an activity sensor.

27. The method of claim 25, wherein the at least one implantable physiologic sensor is located in the implant.

28. The method of claim 20, wherein measuring the first set of intra-abdominal pressure values further includes sensing the intra-abdominal pressure using a second pressure sensor implanted at least partially within the abdomen of the patient, and averaging an output of the at least one pressure sensor and the second pressure sensor to obtain the first set of intra-abdominal pressure values.

29. The method of claim 28, wherein measuring the plurality of second sets of intra-abdominal pressure values includes sensing intra-abdominal pressure at the periodic intervals using the second pressure sensor, and averaging an output of the at least one pressure sensor and the second pressure sensor generated at the periodic intervals.

30. The method of claim 20, wherein determining if there is a difference between the first set of intra-abdominal pressure values and any one or a plurality of the second set of intra-abdominal pressure values includes detecting an onset of renal failure, ascites, or early decompensation.

31. The method of claim 30, further comprising alerting a clinician upon detection of the onset of renal failure, ascites, and/or early decompensation.

32. The method of claim 20, wherein remotely transmitting the first and second sets of intra-abdominal pressure values to one or both of the external device and the implant within the patient includes remotely transmitting the values through acoustic, RF, or optical communication.

33. The method of claim 20, wherein a baseline intra-abdominal pressure is calculated from the first set of intra-abdominal pressure values.

34. A method of monitoring heart functions of a patient, the method comprising:

measuring a plurality of intra-abdominal pressure values of the patient using a first implanted pressure sensor; and

determining whether one or more measured intra-abdominal pressure values exceeds a predetermined threshold value indicative of deteriorating heart condition.

35. The method of claim 34, wherein the deteriorating heart condition is one or more of ascites and compromised renal function.

36. The method of claim 34, further comprising remotely transmitting the intra-abdominal pressure values to one or both of an external device and an implant within the patient.

37. The method of claim 36, wherein remotely transmitting the intra-abdominal pressure values to one or both of the external device and the implant within the patient includes remotely transmitting the values through acoustic, RF, or optical communication.

38. The method of claim 34, wherein measuring a plurality of intra-abdominal pressure values includes measuring a first intra-abdominal pressure value of the patient as a baseline intra-abdominal pressure value and chronically measuring a plurality of second intra-abdominal pressure values of the patient at periodic intervals.

39. The method of claim 38, further comprising associating the first and second intra-abdominal pressure values with an output from at least one second implantable physiologic sensor to obtain a plurality of correlated intra-abdominal pressure values.

40. The method of claim 34, wherein measuring the plurality of intra-abdominal pressure values further includes measuring the intra-abdominal pressure values using a second pressure sensor implanted at least partially within the abdomen of the patient, and averaging an output of the first and second pressure sensors to obtain the intra-abdominal pressure values.